Real-world (RW) outcomes for brexucabtagene autoleucel (Brexu-Cel) treatment in patients (Pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) by high-risk features and prior treatments: Updated evidence from the CIBMTR® registry Meeting Abstract
| Authors: | Wudhikarn, K.; Bezerra, E.; Yang, Y.; Perales, M. A.; Jain, N.; Gergis, U.; Aribi, A.; Hill, L.; Leonard, J. T.; Lutfi, F.; Kim, S.; Bye, M.; Hu, Z. H.; Wang, H. L.; Luo, Z. C.; Siddiqi, R.; Khalid, R. D.; Speiser, J.; Pasquini, M. C.; Kebriaei, P.; Muffly, L. |
| Abstract Title: | Real-world (RW) outcomes for brexucabtagene autoleucel (Brexu-Cel) treatment in patients (Pts) with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) by high-risk features and prior treatments: Updated evidence from the CIBMTR® registry |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 5092 |
| End Page: | 5093 |
| Language: | English |
| ACCESSION: | WOS:001412453500002 |
| DOI: | 10.1182/blood-2024-198455 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
